Boxer Capital

Venture capital firm

Recent changes

  1. Jun 30, 2026Invested in Flare Therapeutics (Series C, $85M) GlobeNewswire

Portfolio

1 total

Recent Investment Activity

1

Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months

Co-Investors

8

Similar Firms

overlapping sector, stage or region

Latest Pulse

  1. Flare Therapeutics Raises $85M, Names New CEOFlare Therapeutics closed an $85 million insider-led Series C and named Anna Protopapas CEO, funding its first-in-class ARON-targeting degrader for prostate cancer toward a Phase 1A trial expected in Q3 2026.→

Boxer Capital FAQ

What companies has Boxer Capital invested in?

Boxer Capital's portfolio includes Flare Therapeutics.

Who does Boxer Capital co-invest with most?

In the rounds Value Add tracks, Boxer Capital most often invests alongside Casdin Capital (1 shared deal), Eli Lilly (1 shared deal), Eli Lilly and Company (1 shared deal), GordonMD Global Investments (1 shared deal), Invus (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction